Serial Number | 79195512 |
Word Mark | RIVOPHARM |
Filing Date | Tuesday, July 26, 2016 |
Status | 709 - CANCELLED - SECTION 71 |
Status Date | Friday, January 19, 2024 |
Registration Number | 5234473 |
Registration Date | Tuesday, July 4, 2017 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, April 18, 2017 |
Goods and Services | Pharmaceutical preparations, both prescription and over-the-counter, namely, pharmaceutical preparations for peptic ulcer and gastrooesophageal reflux disease (GORD), propulsives, intestinal anti-infectives, intestinal anti-inflammatory agents, oral pharmaceutical preparations for lowering blood glucose, Vitamin A and D, mixed vitamin preparations consisting of vitamins A and D, vitamin and mineral preparations for medical use, vitamin C in the nature of ascorbic acid mixed vitamin preparations consisting partially of Vitamin C, calcium supplements, mineral supplements, anti-thrombotic agents, intravenous solutions, cardiac glycosides, class I and class III anti-arrhythmics, pharmaceutical preparations for cardiac stimulation excluding cardiac glycosides, Vasodilators used in the treatment of cardiac diseases, anti-adrenergic agents, pharmaceutical preparations for acting on arteriolar smooth muscle, Beta blocking agents, Selective calcium channel blockers, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors, pharmaceutical preparations in the nature of Angiotensin Converting Enzyme inhibitors combined with other pharmaceutical preparations, anti-fungals for systemic use, anti-infectives and antiseptics, excluding those combined with corticosteroids, oxytocics, plain corticosteroids for systemic use, thyroid preparations, anti-thyroid preparations, tetracyclines preparations, macrolides, lincosamides and streptogramins, aminoglycoside antibacterials, quinolone antibacterials, antimycotics for systemic use, direct acting antivirals, immune sera, bacterial vaccines, alkylating agents, anti-metabolites, plant alkaloids, cytotoxic antibiotics, hormone antagonists and related agents, namely, anti-estrogens, anti-androgens and enzyme inhibitors, immunosuppressive agents, antiinflammatory and antirheumatic preparations, non-steroids in the nature of butylpyrazolidines, acetic acid derivatives, oxicams, propionic acid derivatives, fenamates, Coxibs, muscle relaxants, peripherally acting agents in the nature of curare alkaloids and choline derivatives, antigout preparations, analgesics and antipyretics preparations, anti-migraine preparations, anti-epileptic preparations, anti-cholinergic agents, dopaminergic agents, anti-psychotics, anxiolytics, hypnotics and sedatives, antidepressants, parasympathomimetics, agents for use against amoebiasis and other protozoal diseases, anti-malarial preparation, adrenergics, inhalant anesthetics, adrenergics for systemic use, antihistamines for systemic use, diuretic agents |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | F - NOT AVAILABLE |
Class Status Date | Friday, January 19, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | RIVOPHARM S.A. |
Party Type | 30 - Original Registrant |
Legal Entity Type | 99 - Other |
Address | CH |
Party Name | RIVOPHARM S.A. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | CH |
Party Name | RIVOPHARM S.A. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | CH |
Event Date | Event Description |
Friday, January 19, 2024 | CANCELLED SECTION 71 |
Monday, July 4, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Friday, November 3, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Friday, October 13, 2017 | NOTIFICATION PROCESSED BY IB |
Tuesday, October 10, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
Tuesday, October 10, 2017 | FINAL DISPOSITION PROCESSED |
Wednesday, October 4, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, July 4, 2017 | REGISTERED-PRINCIPAL REGISTER |
Tuesday, April 18, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, April 18, 2017 | PUBLISHED FOR OPPOSITION |
Wednesday, March 29, 2017 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, March 29, 2017 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, March 29, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Friday, March 10, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Monday, March 6, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, March 6, 2017 | DATA MODIFICATION COMPLETED |
Friday, March 3, 2017 | ASSIGNED TO LIE |
Thursday, March 2, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, March 2, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, March 2, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, March 1, 2017 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, March 1, 2017 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Friday, December 9, 2016 | REFUSAL PROCESSED BY IB |
Tuesday, November 15, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Tuesday, November 15, 2016 | REFUSAL PROCESSED BY MPU |
Friday, November 11, 2016 | APPLICATION FILING RECEIPT MAILED |
Wednesday, November 9, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Tuesday, November 8, 2016 | NON-FINAL ACTION WRITTEN |
Monday, November 7, 2016 | ASSIGNED TO EXAMINER |
Monday, November 7, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, November 3, 2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |